20-32447727-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001256798.2(NOL4L):c.1912G>A(p.Val638Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,346,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001256798.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOL4L | NM_001256798.2 | c.1912G>A | p.Val638Met | missense_variant | 11/11 | ENST00000621426.7 | NP_001243727.1 | |
NOL4L | NM_080616.6 | c.1180G>A | p.Val394Met | missense_variant | 8/8 | NP_542183.2 | ||
NOL4L | NM_001351680.2 | c.*69G>A | 3_prime_UTR_variant | 9/9 | NP_001338609.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOL4L | ENST00000621426.7 | c.1912G>A | p.Val638Met | missense_variant | 11/11 | 5 | NM_001256798.2 | ENSP00000483523.1 | ||
NOL4L | ENST00000359676.9 | c.1180G>A | p.Val394Met | missense_variant | 8/8 | 2 | ENSP00000352704.5 |
Frequencies
GnomAD3 genomes AF: 0.0000143 AC: 2AN: 139718Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000164 AC: 4AN: 243652Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132482
GnomAD4 exome AF: 0.0000141 AC: 17AN: 1207074Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 8AN XY: 597492
GnomAD4 genome AF: 0.0000143 AC: 2AN: 139718Hom.: 0 Cov.: 31 AF XY: 0.0000147 AC XY: 1AN XY: 67820
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at